港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

来凯医药-B

14.550

+1.1308.42%

成交量：782.31万

成交额：1.12亿

市值：64.89亿

市盈率：-18.71

高：14.800

开：13.430

低：13.430

收：13.420

52周最高：23.500

52周最低：8.100

股本：4.46亿

香港流通股本：4.46亿

量比：1.94

换手率：1.75%

股息：- -

股息率：- -

每股收益(LYR):-0.778

净资产收益率：-34.59%

总资产收益率：-19.92%

市净率：8.32

市盈率(LYR):-18.71

市销率: 1282.58

数据加载中...

总览公司新闻资讯公告

港股异动 | 来凯医药-B(02105)再涨超9% 乳腺癌候选新药LAE002斩获20.45亿元BD大单

来凯医药-B(02105.HK)涨超9%

每日经济新闻

港股异动 | 来凯医药-B(02105)逆市涨近7% 乳腺癌明星靶点斩获20.45亿元BD大单巩固增肌减脂基本盘

全球前二，收获大单

阿基米德Biotech

烧钱研发、持续亏损，来凯医药借力加速商业化突围

每日卖空追踪 | 来凯医药-B 11月13日卖空量成交13.5万股，卖空比例为6.83%

阿斯利康抢跑，超20亿元授权，还能帮来凯医药赢得多大商业机会？

来凯医药-B盘中异动大幅拉升5.13%

港股生物医药股逆势走高！百济神州涨超7%，百奥赛图-B涨超6%

老虎资讯综合

北大医药董事长徐晰人被正式批捕；安道药业完成超4亿元C轮融资

每日经济新闻

新事丨齐鲁医药斥资20亿，引进乳腺癌新药

来凯医药-B盘中异动快速上涨6.01%报12.000港元

来凯医药-B(02105)与齐鲁制药就LAE 002 (AFURESERTIB)签订中国地区的独家许可协议

医药领域，这些潜力赛道即将爆发！

每日卖空追踪 | 来凯医药-B 11月11日卖空量成交31.4万股，卖空比例为8.19%

背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场

每日卖空追踪 | 来凯医药-B 11月07日卖空量成交18.35万股，卖空比例为3.77%

来凯医药-B11月06日主力净流出121.6万元散户资金买入

每日卖空追踪 | 来凯医药-B 11月05日卖空量成交24万股，卖空比例为9.84%

每日卖空追踪 | 来凯医药-B 11月03日卖空量成交14.55万股，卖空比例为7.2%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02105/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02105","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"来凯医药-B","latestPrice":14.55,"timestamp":1763366895003,"preClose":13.42,"halted":0,"volume":7823100,"delay":0,"floatShares":446000000,"shares":446000000,"eps":-0.7775444775075208,"marketStatus":"未开盘","change":1.13,"latestTime":"11-17 16:08:15","open":13.43,"high":14.8,"low":13.43,"amount":111820363,"amplitude":0.102086,"askPrice":14.55,"askSize":3000,"bidPrice":14.53,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.7151247142090902,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":0,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":13.42,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"volumeRatio":1.938743,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","floatShares":446000000,"roa":"-19.92%","roe":"-34.59%","lyrEps":-0.777544,"volumeRatio":1.938743,"shares":446000000,"dividePrice":0,"high":14.8,"amplitude":0.102086,"preClose":13.42,"low":13.43,"week52Low":8.1,"pbRate":"8.32","psRate":"1282.58","week52High":23.5,"institutionHeld":0,"latestPrice":14.55,"committee":-0.333333,"eps":-0.7775444775075208,"divideRate":0,"volume":7823100,"delay":0,"ttmEps":-0.7151247142090902,"open":13.43,"prevYearClose":9.37,"prevWeekClose":13.42,"prevMonthClose":11.76,"prevQuarterClose":17.2,"fiveDayClose":10.56,"twentyDayClose":13.63,"sixtyDayClose":17.46},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02105\",params:#limit:5,,,undefined,":[{"date":"2025-08-13","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755048600000,"name":null,"time":"","dateTimestamp":1755014400000,"actualEps":null},{"date":"2025-03-24","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盘后","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-16","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723771800000,"name":null,"time":"盘后","dateTimestamp":1723737600000,"actualEps":null},{"date":"2024-03-26","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-24","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692840600000,"name":null,"time":"","dateTimestamp":1692806400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02105\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02105\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1754582400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02105\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02105","date":"2025-11-14","current":-20.350509,"percent":0.173175,"low":-30.832985,"twenty":-19.976892,"median":-9.450099,"eighty":-5.103965,"high":-1.640852,"avg":-11.856608,"sd":7.634491,"marketCap":5612828038},"quantilePoints":[{"date":"2023-06-30","current":-7.785551,"twenty":-6.73679,"median":-5.163648,"eighty":-3.590506,"marketCap":6577091901},{"date":"2023-07-07","current":-6.912426,"twenty":-7.480081,"median":-7.023469,"eighty":-6.753459,"marketCap":5828099229},{"date":"2023-07-14","current":-6.415246,"twenty":-7.354402,"median":-6.80281,"eighty":-6.620389,"marketCap":5484810921},{"date":"2023-07-21","current":-6.50021,"twenty":-7.00126,"median":-6.637911,"eighty":-6.415921,"marketCap":5531622963},{"date":"2023-07-28","current":-6.387862,"twenty":-6.910347,"median":-6.626959,"eighty":-6.393338,"marketCap":5430196872},{"date":"2023-08-04","current":-6.872048,"twenty":-6.916775,"median":-6.645885,"eighty":-6.415921,"marketCap":5851505250},{"date":"2023-08-11","current":-8.062915,"twenty":-7.354402,"median":-6.732662,"eighty":-6.423028,"marketCap":6826756125},{"date":"2023-08-18","current":-6.496848,"twenty":-7.428921,"median":-6.729682,"eighty":-6.45189,"marketCap":5461404900},{"date":"2023-08-25","current":-8.440637,"twenty":-7.525288,"median":-6.804775,"eighty":-6.49752,"marketCap":6327427677},{"date":"2023-09-01","current":-9.089804,"twenty":-8.007442,"median":-6.902032,"eighty":-6.501491,"marketCap":6842360139},{"date":"2023-09-08","current":-6.586545,"twenty":-8.136633,"median":-6.907229,"eighty":-6.507456,"marketCap":4899660396},{"date":"2023-09-15","current":-5.932237,"twenty":-8.007442,"median":-6.869978,"eighty":-6.423028,"marketCap":4447143990},{"date":"2023-09-22","current":-6.606383,"twenty":-7.784235,"median":-6.883282,"eighty":-6.45189,"marketCap":4930868424},{"date":"2023-09-29","current":-7.14814,"twenty":-7.744431,"median":-6.894516,"eighty":-6.45189,"marketCap":5344374795},{"date":"2023-10-06","current":-7.631816,"twenty":-7.631816,"median":-6.912426,"eighty":-6.496848,"marketCap":5703267117},{"date":"2023-10-13","current":-8.856112,"twenty":-8.155063,"median":-6.923868,"eighty":-6.50021,"marketCap":6608299929},{"date":"2023-10-20","current":-8.199572,"twenty":-8.313082,"median":-7.000277,"eighty":-6.506614,"marketCap":6108971481},{"date":"2023-10-27","current":-9.816471,"twenty":-8.453817,"median":-7.029823,"eighty":-6.509983,"marketCap":7310480559},{"date":"2023-11-03","current":-11.65035,"twenty":-8.539495,"median":-7.190868,"eighty":-6.562195,"marketCap":8699237805},{"date":"2023-11-10","current":-10.973476,"twenty":-8.805599,"median":-7.285091,"eighty":-6.584244,"marketCap":8192107350},{"date":"2023-11-17","current":-11.729885,"twenty":-9.08956,"median":-7.4166,"eighty":-6.600627,"marketCap":8835772927},{"date":"2023-11-24","current":-11.685472,"twenty":-9.394133,"median":-7.490817,"eighty":-6.605936,"marketCap":8874782962},{"date":"2023-12-01","current":-9.84176,"twenty":-10.15546,"median":-7.577915,"eighty":-6.610422,"marketCap":7505530734},{"date":"2023-12-08","current":-7.796477,"twenty":-9.900606,"median":-7.778973,"eighty":-6.615093,"marketCap":5921723313},{"date":"2023-12-15","current":-9.518573,"twenty":-9.821529,"median":-7.782262,"eighty":-6.63353,"marketCap":7271470524},{"date":"2023-12-22","current":-9.095699,"twenty":-9.838318,"median":-7.864399,"eighty":-6.64429,"marketCap":6943786230},{"date":"2023-12-29","current":-10.114857,"twenty":-10.007865,"median":-8.108989,"eighty":-6.673018,"marketCap":7762996965},{"date":"2024-01-05","current":-7.064143,"twenty":-9.846254,"median":-7.963657,"eighty":-6.71691,"marketCap":5383384830},{"date":"2024-01-12","current":-6.507833,"twenty":-9.8409,"median":-7.785551,"eighty":-6.71691,"marketCap":4962076452},{"date":"2024-01-19","current":-6.147909,"twenty":-9.833261,"median":-7.674627,"eighty":-6.639506,"marketCap":4681204200},{"date":"2024-01-26","current":-4.037471,"twenty":-9.789285,"median":-7.606263,"eighty":-6.604594,"marketCap":3062287747},{"date":"2024-02-02","current":-1.910591,"twenty":-9.668744,"median":-7.523229,"eighty":-6.508431,"marketCap":1447272298},{"date":"2024-02-09","current":-1.972972,"twenty":-9.600955,"median":-7.449769,"eighty":-6.45189,"marketCap":1501886347},{"date":"2024-02-16","current":-2.11088,"twenty":-9.539168,"median":-7.4166,"eighty":-6.417948,"marketCap":1607213442},{"date":"2024-02-23","current":-1.782124,"twenty":-9.334553,"median":-7.285091,"eighty":-6.285716,"marketCap":1349747211},{"date":"2024-03-01","current":-3.73704,"twenty":-9.184661,"median":-7.220535,"eighty":-6.16588,"marketCap":2832128541},{"date":"2024-03-08","current":-3.812556,"twenty":-9.158571,"median":-7.14814,"eighty":-5.783471,"marketCap":2890643593},{"date":"2024-03-15","current":-3.774736,"twenty":-9.108268,"median":-7.054895,"eighty":-5.122231,"marketCap":2859435565},{"date":"2024-03-22","current":-3.314294,"twenty":-9.090983,"median":-7.029823,"eighty":-4.16949,"marketCap":2508345250},{"date":"2024-03-28","current":-5.557677,"twenty":-9.089621,"median":-7.000277,"eighty":-4.108477,"marketCap":2219670991},{"date":"2024-04-05","current":-4.994454,"twenty":-9.061533,"median":-6.958518,"eighty":-4.159233,"marketCap":1993412788},{"date":"2024-04-12","current":-4.698569,"twenty":-8.939101,"median":-6.914215,"eighty":-4.187247,"marketCap":1876382683},{"date":"2024-04-19","current":-5.074098,"twenty":-8.895252,"median":-6.907229,"eighty":-4.270544,"marketCap":2024620816},{"date":"2024-04-26","current":-6.049449,"twenty":-8.886537,"median":-6.872048,"eighty":-4.439166,"marketCap":2410820163},{"date":"2024-05-03","current":-6.122202,"twenty":-8.8768,"median":-6.815159,"eighty":-4.698569,"marketCap":2438127187},{"date":"2024-05-10","current":-6.43996,"twenty":-8.86224,"median":-6.755587,"eighty":-4.994454,"marketCap":2570761306},{"date":"2024-05-17","current":-7.203002,"twenty":-8.857338,"median":-6.782134,"eighty":-5.0499,"marketCap":2871138576},{"date":"2024-05-24","current":-4.794357,"twenty":-8.851703,"median":-6.739573,"eighty":-4.885401,"marketCap":2754108471},{"date":"2024-05-31","current":-4.572395,"twenty":-8.804497,"median":-6.721699,"eighty":-4.757241,"marketCap":2629276359},{"date":"2024-06-07","current":-4.421848,"twenty":-8.685949,"median":-6.645885,"eighty":-4.615745,"marketCap":2539553278},{"date":"2024-06-14","current":-3.882014,"twenty":-8.64394,"median":-6.616008,"eighty":-4.537135,"marketCap":2227472998},{"date":"2024-06-21","current":-3.862906,"twenty":-8.598267,"median":-6.605265,"eighty":-4.402835,"marketCap":2211868984},{"date":"2024-06-28","current":-3.550986,"twenty":-8.56584,"median":-6.575038,"eighty":-4.108477,"marketCap":2032422823},{"date":"2024-07-05","current":-3.292704,"twenty":-8.553381,"median":-6.507833,"eighty":-3.906941,"marketCap":1884184690},{"date":"2024-07-12","current":-3.669077,"twenty":-8.541472,"median":-6.498529,"eighty":-3.863311,"marketCap":2102640886},{"date":"2024-07-19","current":-2.927038,"twenty":-8.530589,"median":-6.44065,"eighty":-3.81922,"marketCap":1677431505},{"date":"2024-07-26","current":-2.773786,"twenty":-8.516747,"median":-6.41868,"eighty":-3.760814,"marketCap":1595510431},{"date":"2024-08-02","current":-3.12148,"twenty":-8.510893,"median":-6.387862,"eighty":-3.652511,"marketCap":1794461610},{"date":"2024-08-09","current":-2.9997,"twenty":-8.480176,"median":-6.325017,"eighty":-3.53511,"marketCap":1735946557},{"date":"2024-08-16","current":-3.214159,"twenty":-8.413826,"median":-6.28512,"eighty":-3.427,"marketCap":1860778669},{"date":"2024-08-23","current":-6.604067,"twenty":-8.372166,"median":-6.272718,"eighty":-3.478589,"marketCap":2129947911},{"date":"2024-08-30","current":-6.163541,"twenty":-8.347233,"median":-6.28512,"eighty":-3.497821,"marketCap":2001214795},{"date":"2024-09-06","current":-5.314921,"twenty":-8.300967,"median":-6.252611,"eighty":-3.516857,"marketCap":1726510663},{"date":"2024-09-13","current":-5.032211,"twenty":-8.277822,"median":-6.194778,"eighty":-3.53511,"marketCap":1630395636},{"date":"2024-09-20","current":-5.111432,"twenty":-8.256206,"median":-6.170373,"eighty":-3.56099,"marketCap":1665993794},{"date":"2024-09-27","current":-6.057967,"twenty":-8.195708,"median":-6.135055,"eighty":-3.605108,"marketCap":1986377216},{"date":"2024-10-04","current":-7.03444,"twenty":-8.180254,"median":-6.166957,"eighty":-3.621517,"marketCap":2296081191},{"date":"2024-10-10","current":-6.311883,"twenty":-8.160101,"median":-6.193894,"eighty":-3.641637,"marketCap":2046894085},{"date":"2024-10-18","current":-9.026405,"twenty":-8.160101,"median":-6.241014,"eighty":-3.658355,"marketCap":2911929324},{"date":"2024-10-25","current":-10.329157,"twenty":-8.288852,"median":-6.25781,"eighty":-3.667517,"marketCap":3331987588},{"date":"2024-11-01","current":-10.068556,"twenty":-8.453817,"median":-6.28512,"eighty":-3.723447,"marketCap":3250111825},{"date":"2024-11-08","current":-11.890039,"twenty":-8.539495,"median":-6.303819,"eighty":-3.748634,"marketCap":3809002906},{"date":"2024-11-15","current":-12.473246,"twenty":-8.638855,"median":-6.337113,"eighty":-3.770095,"marketCap":3965634801},{"date":"2024-11-22","current":-15.548537,"twenty":-8.857338,"median":-6.401271,"eighty":-3.792036,"marketCap":4941024330},{"date":"2024-11-29","current":-16.918042,"twenty":-8.907392,"median":-6.418623,"eighty":-3.798946,"marketCap":5372620800},{"date":"2024-12-06","current":-17.028741,"twenty":-9.08956,"median":-6.440305,"eighty":-3.809963,"marketCap":5395037855},{"date":"2024-12-13","current":-14.037501,"twenty":-9.184661,"median":-6.496848,"eighty":-3.825885,"marketCap":4438576850},{"date":"2024-12-20","current":-10.693671,"twenty":-9.519989,"median":-6.507224,"eighty":-3.843767,"marketCap":3366294395},{"date":"2024-12-27","current":-10.761363,"twenty":-9.613258,"median":-6.510825,"eighty":-3.853605,"marketCap":3384975274},{"date":"2025-01-03","current":-12.815569,"twenty":-9.789285,"median":-6.563121,"eighty":-3.862906,"marketCap":4035069864},{"date":"2025-01-10","current":-14.889249,"twenty":-9.925093,"median":-6.595306,"eighty":-3.863109,"marketCap":4670219750},{"date":"2025-01-17","current":-11.842286,"twenty":-10.213871,"median":-6.606383,"eighty":-3.864484,"marketCap":3717494921},{"date":"2025-01-24","current":-10.786847,"twenty":-10.358151,"median":-6.624251,"eighty":-3.867614,"marketCap":3407392329},{"date":"2025-01-28","current":-10.88357,"twenty":-10.395234,"median":-6.635203,"eighty":-3.869357,"marketCap":3455962615},{"date":"2025-02-07","current":-10.247352,"twenty":-10.395234,"median":-6.668158,"eighty":-3.877648,"marketCap":3235528242},{"date":"2025-02-14","current":-10.714001,"twenty":-10.679993,"median":-6.721699,"eighty":-3.919404,"marketCap":3381239099},{"date":"2025-02-21","current":-14.934496,"twenty":-10.737429,"median":-6.739573,"eighty":-3.995096,"marketCap":4729998562},{"date":"2025-02-28","current":-14.81818,"twenty":-10.833722,"median":-6.801774,"eighty":-4.034059,"marketCap":4677692101},{"date":"2025-03-07","current":-17.375919,"twenty":-11.045086,"median":-6.869978,"eighty":-4.108477,"marketCap":5507123129},{"date":"2025-03-14","current":-16.002657,"twenty":-11.141514,"median":-6.898274,"eighty":-4.166071,"marketCap":5073726736},{"date":"2025-03-21","current":-15.584553,"twenty":-11.292034,"median":-6.914215,"eighty":-4.215924,"marketCap":4939224407},{"date":"2025-03-28","current":-19.960729,"twenty":-11.418322,"median":-6.958518,"eighty":-4.322429,"marketCap":5432399613},{"date":"2025-04-03","current":-17.71685,"twenty":-11.522026,"median":-7.011873,"eighty":-4.393328,"marketCap":4812194430},{"date":"2025-04-11","current":-14.733536,"twenty":-11.702518,"median":-7.03444,"eighty":-4.445369,"marketCap":3975291051},{"date":"2025-04-17","current":-15.831036,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"marketCap":4281657466},{"date":"2025-04-25","current":-18.85387,"twenty":-11.890039,"median":-7.064143,"eighty":-4.482534,"marketCap":5103616142},{"date":"2025-05-02","current":-20.273816,"twenty":-12.024603,"median":-7.138152,"eighty":-4.483904,"marketCap":5499650777},{"date":"2025-05-09","current":-20.37867,"twenty":-12.272607,"median":-7.171338,"eighty":-4.537135,"marketCap":5566901942},{"date":"2025-05-16","current":-19.209634,"twenty":-12.535336,"median":-7.205238,"eighty":-4.575802,"marketCap":5290424932},{"date":"2025-05-23","current":-24.021586,"twenty":-12.71305,"median":-7.273665,"eighty":-4.590948,"marketCap":6635448220},{"date":"2025-05-30","current":-24.266566,"twenty":-12.811921,"median":-7.298393,"eighty":-4.611692,"marketCap":6732588791},{"date":"2025-06-06","current":-26.139049,"twenty":-13.04892,"median":-7.396066,"eighty":-4.640938,"marketCap":7270598106},{"date":"2025-06-13","current":-29.74055,"twenty":-13.19671,"median":-7.470293,"eighty":-4.681154,"marketCap":8275629397},{"date":"2025-06-20","current":-28.050034,"twenty":-13.86335,"median":-7.533906,"eighty":-4.700982,"marketCap":7789926543},{"date":"2025-06-27","current":-24.148232,"twenty":-14.651862,"median":-7.597268,"eighty":-4.71884,"marketCap":6725116440},{"date":"2025-07-04","current":-23.234874,"twenty":-14.895898,"median":-7.634748,"eighty":-4.738772,"marketCap":6471056485},{"date":"2025-07-11","current":-22.291445,"twenty":-15.089879,"median":-7.696392,"eighty":-4.760215,"marketCap":6202051828},{"date":"2025-07-18","current":-26.31753,"twenty":-15.471722,"median":-7.782262,"eighty":-4.775945,"marketCap":7316474020},{"date":"2025-07-25","current":-25.476909,"twenty":-15.613487,"median":-7.864399,"eighty":-4.786942,"marketCap":7108532126},{"date":"2025-08-01","current":-24.329935,"twenty":-15.664049,"median":-8.108989,"eighty":-4.797184,"marketCap":6746559201},{"date":"2025-08-08","current":-25.903798,"twenty":-15.966112,"median":-8.199572,"eighty":-4.803824,"marketCap":7200950746},{"date":"2025-08-15","current":-26.404653,"twenty":-16.351868,"median":-8.297938,"eighty":-4.809409,"marketCap":6923694888},{"date":"2025-08-22","current":-24.957996,"twenty":-16.76437,"median":-8.37361,"eighty":-4.821672,"marketCap":6523837408},{"date":"2025-08-29","current":-23.625619,"twenty":-17.081215,"median":-8.510167,"eighty":-4.847599,"marketCap":6205046052},{"date":"2025-09-05","current":-24.661552,"twenty":-17.4013,"median":-8.538507,"eighty":-4.876556,"marketCap":6470705516},{"date":"2025-09-12","current":-20.300804,"twenty":-17.709582,"median":-8.5673,"eighty":-4.894937,"marketCap":5336119539},{"date":"2025-09-19","current":-22.387755,"twenty":-18.502396,"median":-8.659194,"eighty":-4.936492,"marketCap":5880503891},{"date":"2025-09-26","current":-23.755076,"twenty":-18.883269,"median":-8.853357,"eighty":-5.007141,"marketCap":6223463577},{"date":"2025-10-03","current":-26.75639,"twenty":-19.317505,"median":-8.86952,"eighty":-5.027379,"marketCap":7026491136},{"date":"2025-10-10","current":-24.099943,"twenty":-19.58973,"median":-8.892896,"eighty":-5.032211,"marketCap":6319659587},{"date":"2025-10-17","current":-21.756329,"twenty":-19.863851,"median":-8.951685,"eighty":-5.039347,"marketCap":5700659177},{"date":"2025-10-24","current":-19.051807,"twenty":-20.078316,"median":-9.089652,"eighty":-5.055065,"marketCap":4993827628},{"date":"2025-10-31","current":-18.736648,"twenty":-20.048899,"median":-9.127121,"eighty":-5.062023,"marketCap":4918543795},{"date":"2025-11-07","current":-16.723664,"twenty":-19.976892,"median":-9.288548,"eighty":-5.072031,"marketCap":4387374524},{"date":"2025-11-14","current":-21.334357,"twenty":-19.976892,"median":-9.450099,"eighty":-5.103965,"marketCap":5612828038}],"updateTime":1763371344539},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02105\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584614756","title":"港股异动 | 来凯医药-B(02105)再涨超9% 乳腺癌候选新药LAE002斩获20.45亿元BD大单","url":"https://stock-news.laohu8.com/highlight/detail?id=2584614756","media":"智通财经","labels":["productRelease"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2584614756?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 14:52","pubTimestamp":1763362368,"startTime":"0","endTime":"0","summary":"消息面上，11月12日，来凯医药将乳腺癌候选新药LAE002 中国地区权益授予齐鲁制药，交易总金额达20.45亿元，而且来凯医药还有权收取十余到二十余百分点的梯度销售分成。LAE002是全球两种处于晚期临床开发阶段的针对乳腺癌及前列腺癌的AKT抑制剂之一。据券商研报，LAE002国内销售峰值预计20亿元左右，全球销售峰值可参考Capivasertib。Capivasertib今年销售预期7-8亿美元，销售峰值预计10-20亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369912.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 来凯医药-B(02105)再涨超9% 乳腺癌候选新药LAE002斩获20.45亿元BD大单","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2584612444","title":"来凯医药-B(02105.HK)涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584612444","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584612444?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 15:08","pubTimestamp":1763363331,"startTime":"0","endTime":"0","summary":"每经AI快讯，来凯医药-B(02105.HK)涨超9%，截至发稿，涨6.71%，报14.32港元，成交额9265.87万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511173566210119.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511173566210119.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2583654738","title":"港股异动 | 来凯医药-B(02105)逆市涨近7% 乳腺癌明星靶点斩获20.45亿元BD大单 巩固增肌减脂基本盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2583654738","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583654738?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 10:17","pubTimestamp":1763086650,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，来凯医药-B逆市涨近7%，截至发稿，涨2.88%，报19港元，成交额2771.1万港元。根据许可协议，来凯最高可获得总额达到人民币20.45亿元的首付款及里程碑款项，以及基于产品净销售额的十余到二十余百分点的梯度分成。LAE002仅为序章，全面验证了来凯的BD能力、临床执行力和资金实力，也巩固了来凯增肌减脂的基本盘。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2583428598","title":"全球前二，收获大单","url":"https://stock-news.laohu8.com/highlight/detail?id=2583428598","media":"阿基米德Biotech","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583428598?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 20:35","pubTimestamp":1763037331,"startTime":"0","endTime":"0","summary":"乳腺癌为全球第二大高发癌种，据世卫组织数据，2022年全球乳腺癌新发患者约230万人，占当年新发癌症患者数量的11.5%。2023年11月，全球首个AKT抑制剂阿斯利康Capivasertib获FDA批准上市，对AKT抑制剂的成药性和商业价值作出双重验证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113205742a49f186a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113205742a49f186a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","02105","BK1574","01477"],"gpt_icon":0},{"id":"2583613975","title":"烧钱研发、持续亏损，来凯医药借力加速商业化突围","url":"https://stock-news.laohu8.com/highlight/detail?id=2583613975","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583613975?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 19:16","pubTimestamp":1763032581,"startTime":"0","endTime":"0","summary":"在持续亏损和行业竞争的双重压力下，来凯医药迎来了商业化的关键动作。11月12日，来凯医药发布公告，宣布与齐鲁制药有限公司（以下简称“齐鲁制药”）订立独家许可协议，后者获授独家许可，于中国地区（包括中国内地、香港特别行政区、澳门特别行政区及台湾地区）进行LAE002（afuresertib）的研究、开发及商业化，整体协议金额最高达20.45亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511133563707070.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511133563707070.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2583568988","title":"每日卖空追踪 | 来凯医药-B 11月13日卖空量成交13.5万股，卖空比例为6.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583568988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583568988?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 16:30","pubTimestamp":1763022629,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间11月13日，涨2.22%，卖空量成交13.5万股，较上一交易日减少60.64%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113163355a49e8687&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113163355a49e8687&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2583056860","title":"阿斯利康抢跑，超20亿元授权，还能帮来凯医药赢得多大商业机会？","url":"https://stock-news.laohu8.com/highlight/detail?id=2583056860","media":"钛媒体APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583056860?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 10:51","pubTimestamp":1763002273,"startTime":"0","endTime":"0","summary":"消息公布后，市场情绪也被带动，今日来凯医药早盘高开超4%。即将“登场亮相”的LAE002是来凯医药的核心管线之一。而且，对比阿斯利康这样的老牌跨国医药巨头，来凯医药在产品研发、商业等方面的积累相对薄弱。等待另一驾马车接力这些年，“亏损”已经是来凯医药的一个经营常态。据悉，2024年11月，来凯医药与礼来签订了一项临床合作协议，旨在支持和加速LAE102针对肥胖症治疗的全球临床开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113105636a49dd2f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113105636a49dd2f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2583568603","title":"来凯医药-B盘中异动 大幅拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583568603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583568603?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 09:51","pubTimestamp":1762998702,"startTime":"0","endTime":"0","summary":"2025年11月13日早盘09时51分，来凯医药-B股票出现波动，股价快速拉升5.13%。截至发稿，该股报12.300港元/股，成交量34.75万股，换手率0.08%，振幅4.87%。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。来凯医药-B股票所在的生物技术行业中，整体涨幅为3.95%。其相关个股中，百济神州、百奥赛图-B、映恩生物-B涨幅较大，振幅较大的相关个股有百奥赛图-B、永泰生物-B、映恩生物-B，振幅分别为8.16%、7.96%、6.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113095142a49dab36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113095142a49dab36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"1139577547","title":"港股生物医药股逆势走高！百济神州涨超7%，百奥赛图-B涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139577547","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139577547?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 09:42","pubTimestamp":1762998120,"startTime":"0","endTime":"0","summary":"11月13日，港股生物医药股逆势走高，$百济神州(06160)$涨超7%，$百奥赛图-B(02315)$涨超6%，$映恩生物-B(09606)$涨超5%，$三生制药(01530)$、$信达生物(01801)$、$来凯医药-B(02105)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2097828474.EUR","LU1719994722.HKD","LU2543165471.USD","LU2488822045.USD","LU0307460666.USD","LU2097828557.USD","LU0455707207.USD","02105","BK1588","06160","LU0588546209.SGD","LU0502904849.HKD","LU2097828805.USD","LU1251922891.USD","02315","09939","LU2097828631.EUR","BK1589","BK1593","01801","BK1583","HK0000252160.HKD","LU2097828714.EUR","01530","09606","LU2242644610.SGD","HK0000252152.HKD","ONC","HK0000500386.USD","BK4139","LU1969619763.USD","BK1500","LU1303224171.USD","HK0000165453.HKD","BK4585","LU1770034418.SGD","LU2328871848.SGD","BK4526"],"gpt_icon":0},{"id":"2583568568","title":"北大医药董事长徐晰人被正式批捕；安道药业完成超4亿元C轮融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2583568568","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583568568?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 07:11","pubTimestamp":1762989089,"startTime":"0","endTime":"0","summary":"丨 2025年11月13日星期四丨NO.1北大医药董事长徐晰人被正式批捕北大医药发布公告称，公司于近日经有关部门核实，获悉公司董事长、总裁徐晰人因涉嫌刑事犯罪，已被重庆市江北区人民检察院批准逮捕。点评：安道药业获超4亿元C轮融资，公司聚焦肾疾、贫血及癌症新药赛道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511130720269765ae30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511130720269765ae30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2583788302","title":"新事丨齐鲁医药斥资20亿，引进乳腺癌新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2583788302","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583788302?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 20:43","pubTimestamp":1762951395,"startTime":"0","endTime":"0","summary":"11月12日，来凯医药宣布：与齐鲁制药签订独家许可协议，授予其在中国地区研究、开发及商业化乳腺癌候选新药LAE002 的权益。总的首付款及里程碑款项将达到20.45亿元。LAE002是来凯医药2018年从诺华引进的AKT强效抑制剂，能抑制所有三种 AKT 亚型，目前全球只有两款处于III期临床的针对乳腺癌及前列腺癌的AKT抑制剂，LAE002是其中之一，正开展HR+/HER2-乳腺癌III期临床试验。来凯医药计划于2026年向CDE提交LAE002的新药上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112204529a49c73e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112204529a49c73e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","09939","BK1161","02105"],"gpt_icon":0},{"id":"2583302767","title":"来凯医药-B盘中异动 快速上涨6.01%报12.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583302767","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583302767?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 09:30","pubTimestamp":1762911009,"startTime":"0","endTime":"0","summary":"2025年11月12日早盘09时30分，来凯医药-B股票出现波动，股价大幅拉升6.01%。截至发稿，该股报12.000港元/股，成交量7.55万股，换手率0.02%，振幅1.77%。资金方面，该股资金流入16.799万港元，流出44.6735万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为1.63%。其相关个股中，来凯医药-B、百济神州、映恩生物-B涨幅较大，振幅较大的相关个股有荣昌生物、来凯医药-B、云顶新耀，振幅分别为3.40%、1.77%、0.85%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112093009a6f31b72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112093009a6f31b72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2582199643","title":"来凯医药-B(02105)与齐鲁制药就LAE 002 (AFURESERTIB)签订中国地区的独家许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2582199643","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582199643?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 08:21","pubTimestamp":1762906916,"startTime":"0","endTime":"0","summary":"智通财经APP讯，来凯医药-B 发布公告，于2025年11月12日，集团与齐鲁制药有限公司已订立独家许可协议。根据许可协议，集团有权获得最高总计人民币20.45亿元的首付款及里程碑款项。集团目标于2025年第四季度完成受试者入组，并计划于2026年向中国国家药品监督管理局药品审评中心提交新药上市申请。董事会认为，订立该许可协议符合公司及其股东的整体最佳利益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK1574","BK1191","01477","BK1161"],"gpt_icon":0},{"id":"2582366645","title":"医药领域，这些潜力赛道即将爆发！","url":"https://stock-news.laohu8.com/highlight/detail?id=2582366645","media":"赛柏蓝","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582366645?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 19:13","pubTimestamp":1762859617,"startTime":"0","endTime":"0","summary":"2025年，默克宣布与加拿大AI制药公司Variational AI达成协议，潜在交易总价值达3.49亿美元，默克将利用其AI药物发现平台设计和优化针对两个未公开靶点的小分子候选药物。礼来的Orforglipron在全球口服小分子中进展最快，预计今年年底递交上市申请（图3），国内企业如恒瑞医药、华东医药、闻泰科技等也在该领域积极布局，部分管线已进入临床中后期，展现出较强的出海潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111200654a6f1f725&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111200654a6f1f725&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z4B17.USD","09887","BK4187","BK4007","BK4006","06998","IE00B7SZL793.SGD","IE0031619046.USD","NVO","BK4532","02105","LU2065731478.USD","LU1093756325.SGD","IE00BKVL7J92.USD","LU1093756168.USD","IE00B66KJ199.SGD","IE00BZ1G4Q59.USD","BK4585","LU0154236417.USD","BK4588","01276","LU0963586101.USD","BK4599","CRS"],"gpt_icon":1},{"id":"2582346125","title":"每日卖空追踪 | 来凯医药-B 11月11日卖空量成交31.4万股，卖空比例为8.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582346125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582346125?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 16:30","pubTimestamp":1762849827,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间11月11日，涨7.2%，卖空量成交31.4万股，较上一交易日增加33.9%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111163353a6f18436&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111163353a6f18436&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2582708318","title":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2582708318","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582708318?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 22:45","pubTimestamp":1762785907,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场改写第1、2段，增加辉瑞与Metsera的交易；更新礼来、罗氏、Viking的信息；在第6-7段增加Metsera肥胖症候选药物的细节，在第42-43段增加Scholar Rock的细节。辉瑞PFE.N收购生物技术公司Metsera有望加速其重新进入利润丰厚的肥胖症治疗市场，目前该市场由礼来LLY.N和丹麦竞争对手诺和诺德NOVOb.CO主导。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL4S3WM182:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0097036916.USD","LU0661504455.SGD","LU2089284900.SGD","LU1366192091.USD","LU2491049909.HKD","LU0345777147.USD","LU0203347892.USD","LU0310799852.SGD","ALT","LU0109391861.USD","LU0466842654.USD","LU0471298694.HKD","PFE","LU2491050071.SGD","LU0640476718.USD","MRK","LU2357305700.SGD","LU0011850046.USD","LU0238689110.USD","LU2461242641.AUD","03692","MTSR","LU0965508806.USD","GPCR","03165","LLY","VKTX","OPK","LU1066053197.SGD","AMGN","SRRK","IE00B1XK9C88.USD","LU2237443622.USD","02105","LU2237443978.SGD","LU0985320562.USD","LU1280957306.USD","LU0957799991.USD","AZN.UK","LU1941712264.USD","LU1267930730.SGD","LU0889566641.SGD","LU0171293334.USD","LU1162221912.USD","GB00BDT5M118.USD","LU0545039389.USD","LU1015430645.USD","LU1093756168.USD","LU2491050154.USD","LU0128525689.USD"],"gpt_icon":1},{"id":"2581531738","title":"每日卖空追踪 | 来凯医药-B 11月07日卖空量成交18.35万股，卖空比例为3.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581531738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581531738?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 16:30","pubTimestamp":1762504226,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间11月07日，跌7.82%，卖空量成交18.35万股，较上一交易日减少63%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107163330a48fb0b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107163330a48fb0b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2581999540","title":"来凯医药-B11月06日主力净流出121.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2581999540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581999540?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 16:15","pubTimestamp":1762416954,"startTime":"0","endTime":"0","summary":"11月06日, 来凯医药-B股价跌2.57%，报收11.38元，成交金额2652.9万元，换手率0.53%，振幅8.82%，量比1.01。来凯医药-B今日主力资金净流出121.6万元，上一交易日主力净流入2.3万元。该股近5个交易日上涨0.71%，主力资金累计净流出108.1万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流出104.1万元，其中净流出天数为11日。该股主力净额占比0.02%，港股市场排名2549/2686。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106162116a6e55fea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106162116a6e55fea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2581974423","title":"每日卖空追踪 | 来凯医药-B 11月05日卖空量成交24万股，卖空比例为9.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581974423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581974423?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:30","pubTimestamp":1762331426,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间11月05日，跌2.59%，卖空量成交24万股，较上一交易日减少19.6%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105163338a48a11ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105163338a48a11ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2580924245","title":"每日卖空追踪 | 来凯医药-B 11月03日卖空量成交14.55万股，卖空比例为7.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580924245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580924245?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 16:30","pubTimestamp":1762158626,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间11月03日，涨5.87%，卖空量成交14.55万股，较上一交易日增加31.08%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103163325a6dd6990&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103163325a6dd6990&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":187,"code":"91000000","status":"200"}]}}